| # | Drug | Count |
|---|---|---|
| 0 | LENALIDOMIDE | 237 |
| 1 | RITUXIMAB | 123 |
| 2 | ALLOPURINOL | 114 |
| 3 | GLOFITAMAB | 56 |
| 4 | DEXAMETHASONE | 55 |
| 5 | DEXAMETHASONE 1.5 MG | 55 |
| 6 | ACETAMINOPHEN | 50 |
| 7 | ASPIRIN | 49 |
| 8 | ASPIRIN 325 MG | 48 |
| 9 | ASPIRIN 81 MG | 48 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GLOFITAMAB | 56 | 0.0207 |
| 1 | MOSUNETUZUMAB | 14 | 0.0126 |
| 2 | TAFASITAMAB-CXIX | 9 | 0.0099 |
| 3 | PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION | 12 | 0.0099 |
| 4 | EPCORITAMAB-BYSP | 10 | 0.0075 |
| 5 | MOGAMULIZUMAB-KPKC | 7 | 0.0051 |
| 6 | PILOCARPINE HYDROCHLORIDE | 12 | 0.0047 |
| 7 | TALQUETAMAB-TGVS | 4 | 0.0027 |
| 8 | TECLISTAMAB-CQYV | 6 | 0.0025 |
| 9 | RASBURICASE | 6 | 0.0024 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 66 | 0.0163 |
| 1 | Chemokine Receptor Type 4 Interaction [EPC] | 7 | 0.0051 |
| 2 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 2 | 0.0033 |
| 3 | CD30-directed Immunoconjugate [EPC] | 11 | 0.0011 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 6 | 0.0010 |
| 5 | Thyroid Stimulating Hormone [EPC] | 1 | 0.0010 |
| 6 | Monobactam Antibacterial [EPC] | 2 | 0.0007 |
| 7 | Xanthine Oxidase Inhibitor [EPC] | 114 | 0.0007 |
| 8 | Estrogen Receptor Antagonist [EPC] | 21 | 0.0005 |
| 9 | Autologous Cellular Immunotherapy [EPC] | 3 | 0.0005 |